FORT LEE, N.J., June 20, 2012 /PRNewswire/ -- Herborium
Group, Inc., (HBRM) www.herborium.com, a Botanical
Therapeutics® Company announces today that it has begun
manufacturing its new sexual health product line for women and men.
Herborium proprietary products will launch in the Fall
of 2012 in coordination with a promotion of a unique
Kamasutra vodka product with natural herbs provided by
Herborium and developed based on a know-how associated
with the company's sexual health formulations. Kamasutra
(USA) LLC is a US partner of the
German Bismarck Premium Brands GmbH, www.bismarck.de and
http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.
In addition to revenue sharing (vodka market in the US is
estimated to exceed $4.8 billion) and
licensing fees to be received by Herborium Group in association
with Kamasutra vodka beverage, Herborium plans on leveraging
Kamasutra's promotional strategy linked to Herborium sexual
health product line that provides unprecedented exposure and
promotional opportunities for Herborium women and men products.
Herborium goal is to make a direct impact on over $1.5 billion natural sexual health products
market and also to position its products against the market for
pharmaceutical grade sexual health products that is over
$3.2 billion worldwide, with Viagra
(Pfizer), Cialis (Eli Lilly) and Levitra (Bayer) leading market
share. Rising costs of pharmaceutical grade drugs combined with
safety concerns drive consumers to look for natural alternatives in
a sexual health products category and Herborium's sexual health
formulas are all herbal, proven effective and safe.
There is no Viagra comparative product on the market for women.
Herborium sexual formulation for women will be the only product of
its kind on the market. Female sexual enhancement industry is
expected to grow into a multibillion dollar business especially
since women themselves are becoming increasingly aware of their
sexuality and their sexual health. First-quarter sales of personal
lubricants in the USA soared 32%
to $41.2 million, according to
Information Resources Inc. Herborium product for women is the
only all herbal, proven effective and safe sexual health and
enhancement product for women that improves both a satisfaction and
libido (sexual drive).
Dr. Agnes Olszewski, Chairman and
CEO of Herborium, stated: "We believe that this is the right time
to commercialize our all herbal, proprietary products women and
men. There is nothing on the market as our systemic all herbal
product for women. Unlike many supplements claiming to improve
sexual performance both our products include only herbal
ingredients recognized for their safety. Both products developed by
Herborium are based on a combination of Principles of Traditional
Chinese Medicine and modern sexual health science, have confirmed
up to 98% efficacy and improve performance and experience for those
men and women with sexual performance problems and those seeking
recreational sexual enhancement. Products have no known adverse
effects.
"By combining unique characteristics of Herborium sexual health
Botanical Therapeutics® with a strong marketing exposure and
growing demand, and awareness regarding sexual health, we expect
our products to gain market acceptance and start generating
revenues as early as 2012, with an exponential growth in the next
12 months. Distribution arrangements are presently being made,"
concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to establish
and maintain a differential advantage. The company sells its
products in the US and Europe. For
more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.